|
|
Volumn 11, Issue , 2004, Pages S207-S209
|
|
Pharmacological doses of all-trans retinoic acid promote g0/g1 transition and g1 arrest of normal human marrow cd34 + cells
a,b,c
c
CHU BRETONNEAU
(France)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD34 ANTIGEN;
CD38 ANTIGEN;
DNA;
PROTEIN P27;
RETINOIC ACID;
BONE MARROW CELL;
CELL ASSAY;
CELL COUNT;
CELL CYCLE G0 PHASE;
CELL CYCLE G1 PHASE;
CELL CYCLE G2 PHASE;
CELL CYCLE S PHASE;
CELL DIFFERENTIATION;
CELL ISOLATION;
CELL PROLIFERATION;
CELL VIABILITY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DNA CONTENT;
DRUG MECHANISM;
ERYTHROPOIESIS;
HEART SURGERY;
HUMAN;
HUMAN CELL;
INCUBATION TIME;
INHIBITION KINETICS;
LETTER;
MITOSIS;
MITOSIS INHIBITION;
MONONUCLEAR CELL;
MYELODYSPLASTIC SYNDROME;
PHASE TRANSITION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TREATMENT OUTCOME;
ANTIGENS, CD34;
BONE MARROW CELLS;
CELL CYCLE;
CELL DIFFERENTIATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
G0 PHASE;
G1 PHASE;
GENE EXPRESSION REGULATION;
HUMANS;
TRANSCRIPTION, GENETIC;
TRETINOIN;
|
|
EID: 12744263103
PISSN: 13509047
EISSN: 14765403
Source Type: Journal
DOI: 10.1038/sj.cdd.4401471 Document Type: Editorial |
|
Times cited : (4)
|
|
References (10)
|
